Shock cardiogenic

Ca.rdia.c-AssistDevices. The principal cardiac-assist device, the intra-aortic balloon pump (lABP), is used primarily to support patients before or after open-heart surgery, or patients who go into cardiogenic shock. As of the mid-1990s, the lABP was being used more often to stabilize heart attack victims, especially in community hospitals which do not provide open-heart surgery. The procedure consists of a balloon catheter inserted into the aorta which expands and contracts to assist blood flow into the circulatory system and to reduce the heart s workload by about 20%. The disposable balloon is powered by an external pump console. 

The adrenergic drugs are useful in improving hemodynamic status by improving myocardial contractility and increasing heart rate, which results in increased cardiac output. Peripheral resistance is increased by vasoconstriction. In cardiogenic shock or advanced shock associated with low cardiac output, die adrener-... 

Patient presentation may range from asymptomatic to cardiogenic shock. 

Dopamine is most commonly reserved for patients with low systolic blood pressures and those approaching cardiogenic shock. It may also be used in low doses (less than 3 mcg/kg per minute) to improve renal function in a patient with inadequate urine output despite high filling pressures and volume overload, although this indication is controversial. 

The patient is typically in acute distress and may develop or present with cardiogenic shock. 

ET measured in the plasma appears to be a spillover of the ET that is (locally) released by the endothelium. It is known that low levels of ET (ranging from 0.25 to 5.0 pg/ml) are normally present in the circulation (B8, P12). These levels are increased by 3-10 times in patients with renal failure (S30), diabetes (V3), hypertension, bums (H32), myocardial infarction, primary pulmonary hypertension (N8), and cardiogenic shock (LI, L9, L10, PI, W8). ET is assumed to be released... 

Dobutamine Cardiogenic shock and congestive heart failure... 

Suggested Alternatives for Differential Diagnosis Acute respiratory distress syndrome, congestive heart failure, pulmonary edema, AIDS, pneumonia, cardiogenic shock, septic shock, phosgene toxicity, phosphine toxicity, salicylate toxicity with pulmonary edema, influenza, plague, tularemia, and anthrax. 

Complications of MI include cardiogenic shock, heart failure, valvular dysfunction, various arrhythmias, pericarditis, stroke secondary to left ventricular (LV) thrombus embolization, venous thromboembolism, and LV free-wall rupture. 

Dopamine should generally be avoided in decompensated HF, but its pharmacologic actions may be preferable to dobutamine or milrinone in patients with marked systemic hypotension or cardiogenic shock in the face of elevated ventricular filling pressures, where dopamine in doses greater than 5 mcg/kg/min may be necessary to raise central aortic pressure. 

The intraaortic balloon pump (IABP) is typically employed in patients with advanced HF who do not respond adequately to drug therapy, such as those with intractable myocardial ischemia or patients in cardiogenic shock. 

Shock refers to conditions manifested by hemodynamic alterations (e.g., hypotension, tachycardia, low cardiac output [CO], and oliguria) caused by intravascular volume deficit (hypovolemic shock), myocardial pump failure (cardiogenic shock), or peripheral vasodilation (septic, anaphylactic, or neurogenic shock). The underlying problem in these situations is inadequate tissue perfusion resulting from circulatory failure. 

Hypotension, tachycardia, tachypnea, confusion, and oliguria are common symptoms. Myocardial and cerebral ischemia, pulmonary edema (cardiogenic shock), and multisystem organ failure often follow. Significant hypotension (systolic blood pressure [SBP] less than 90mmHg) with reflex sinus tachycardia (greater than 120 beats/min) and increased... 

Cardiac failure (dysrhythmias, arrest, cardiogenic shock)... 

Finally, you can increase norepinephrine activity by directly stimulating norepinephrine alpha-1 and beta receptors. Some medicines that are used to treat asthma and cardiogenic shock work in this manner, but no psychiatric medications do so. 

Ivabradine is used in the treatment of angina in patients in normal sinus rhythm. It acts on the sinus node resulting in a reduction of the heart rate. It is contraindicated in severe bradycardia (heart rate lower than 60 beats/ minute), cardiogenic shock, acute myocardial infarction, moderate-to-severe heart failure, immediately after a cerebrovascular accident, second and third-degree heart block and patients with unstable angina or a pacemaker. Side-effects include bradycardia, first-degree heart block, ventricular extrasystoles, headache, dizziness and visual disturbances, including blurred vision. 

In medical practice, a-adrenoblockers are drngs that block a - and o -adrenoreceptors, and they are nsed relatively rarely. The most important effect of a-adrenoblockers is the dilation of blood vessels, for which they are nsed in various disturbances of peripheral blood flow, and hemorrhagic and cardiogenic shock, in which the typical effect is a spasm of the arterioles. 

Cardiogenic shock preexisting second- or third-degree AV block (if no pacemaker is present) congenital QT prolongation sick sinus syndrome hypersensitivity to disopyramide. 

Uncontrolled CHF cardiogenic shock sinoatrial, AV and intraventricular disorders of impulse generation or conduction (eg, sick sinus node syndrome, AV block) in the absence of an artificial pacemaker bradycardia marked hypotension bronchospastic disorders manifest electrolyte imbalance hypersensitivity to the drug. 

Preexisting second- or third-degree AV block, right bundle branch block when associated with a left hemiblock (bifascicular block), unless a pacemaker is present to sustain the cardiac rhythm if complete heart block occurs recent myocardial infarction (Ml) presence of cardiogenic shock hypersensitivity to the drug. 

Parenteral Marked sinus bradycardia second- and third-degree AV block unless a functioning pacemaker is available cardiogenic shock. 

---